SMA is clinically classified into types based on severity and age of onset, whereby SMN2 gene copy number is the major disease modifier, as a greater number of SMN2 copies results in a larger amount of functional full-length SMN protein being produced [11]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.